A whistleblower working in the medical industry contacted The Daily Telegraph with concerns that specific pharmaceutical companies were colluding with some chemists to exploit the NHS pricing system that covered specials.
Following the allegations, Daily Telegraph reporters posed as representatives of an investment group in the process of buying pharmacies.
They arranged meetings with five companies to discuss “deals” available to potential clients and found that companies were prepared to offer “incentives” and large discounts to win business.
The market for specials is keenly chased by drugs firms as – despite it involving taxpayers’ money – “the profits are very high”.
No comments:
Post a Comment